Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 16328-62-4 | MDL No. : | MFCD00464845 |
Formula : | C6H5N3O | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | PGDIPOWQYRAOSK-UHFFFAOYSA-N |
M.W : | 135.12 | Pubchem ID : | 519250 |
Synonyms : |
|
Num. heavy atoms : | 10 |
Num. arom. heavy atoms : | 9 |
Fraction Csp3 : | 0.0 |
Num. rotatable bonds : | 0 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 2.0 |
Molar Refractivity : | 36.71 |
TPSA : | 61.54 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -7.24 cm/s |
Log Po/w (iLOGP) : | 0.79 |
Log Po/w (XLOGP3) : | -0.17 |
Log Po/w (WLOGP) : | 0.25 |
Log Po/w (MLOGP) : | 0.03 |
Log Po/w (SILICOS-IT) : | 1.75 |
Consensus Log Po/w : | 0.53 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -1.24 |
Solubility : | 7.84 mg/ml ; 0.058 mol/l |
Class : | Very soluble |
Log S (Ali) : | -0.67 |
Solubility : | 29.1 mg/ml ; 0.215 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -2.41 |
Solubility : | 0.522 mg/ml ; 0.00386 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.5 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H332-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
[ 40851-98-7 ]
5-Chloro-1H-imidazo[4,5-b]pyridin-2(3H)-one
Similarity: 0.88
[ 148038-83-9 ]
6-Bromo-1H-imidazo[4,5-b]pyridin-2(3H)-one
Similarity: 0.86
[ 185961-99-3 ]
1-(Piperidin-4-yl)-1H-imidazo[4,5-b]pyridin-2(3H)-one
Similarity: 0.84
[ 29448-81-5 ]
1H-Imidazo[4,5-b]pyridine-2(3H)-thione
Similarity: 0.78
[ 40851-98-7 ]
5-Chloro-1H-imidazo[4,5-b]pyridin-2(3H)-one
Similarity: 0.88
[ 148038-83-9 ]
6-Bromo-1H-imidazo[4,5-b]pyridin-2(3H)-one
Similarity: 0.86
[ 185961-99-3 ]
1-(Piperidin-4-yl)-1H-imidazo[4,5-b]pyridin-2(3H)-one
Similarity: 0.84
[ 29448-81-5 ]
1H-Imidazo[4,5-b]pyridine-2(3H)-thione
Similarity: 0.78
[ 67074-71-9 ]
1-Methylpyrido[2,3-b]pyrazine-2,3(1H,4H)-dione
Similarity: 0.73